Diabetes management leader Dexcom expands presence in EMEA markets with new Edinburgh HQ
November 14, 2016 09:00 AM PST
EDINBURGH, Scotland, Nov. 14, 2016 - Dexcom, a leader in continuous glucose monitoring (CGM) for patients with diabetes, today announced the opening of its EMEA HQ in Edinburgh, Scotland, creating over 60 new jobs for the region within the next three years.
The office was officially inaugurated by Keith Brown MSP, Cabinet Secretary for the Economy, Jobs and Fair Work, on World Diabetes Day and will support various Dexcom business functions for Europe, the Middle-East and Africa.
This is a significant milestone as it provides patients across the EMEA regions with access to Dexcom’s world-class technology, which includes a CGM sensor that sits just below the skin's surface and is attached to a transmitter which wirelessly transfers real-time glucose levels every five minutes to mobile applications via Bluetooth.
The new premises, based in Tanfield, enjoy the support of Scottish Enterprise and serve as the launch pad to distribute Dexcom’s suite of Mobile CGM Systems into EMEA markets. The company's latest offering, the Dexcom G5 Mobile CGM System is the world’s first mobile CGM system.
"With its strong history of medical innovation, the incredible talent pool in the city and the strategic inward investment through Scottish Enterprise, Edinburgh really stood out to us as a location," explained John Lister, General Manager, EMEA, of Dexcom. "We are excited to bring the benefits of our state-of-the-art glucose monitoring solutions to diabetes patients across Europe, Africa and the Middle East, and build our brand and future commercial business from Scotland."
Cabinet Secretary for the Economy, Jobs and Fair Work, Keith Brown, said: “On a day like World Diabetes Day, a day that reminds us of the challenges faced by people living with diabetes, I am particularly pleased that an international company like Dexcom recognises the strength of Scotland’s life science sector and chose Edinburgh as their new European headquarters. I look forward to hearing of technological advances developed here that will enhance the lives of people living with diabetes and I wish them all the best for the future.”
Managing Director of Scottish Development International, Paul Lewis, said: “With exceptional strengths in both life sciences and digital technologies, Scotland is the ideal location for Dexcom’s European headquarters. The company will now join the many international investors who benefit from our competitive business environment, strong skills base and effective support network, which help make Scotland the top performing location for inward investment after London. We look forward to supporting Dexcom’s ambitious growth plans for Europe, the Middle-East and Africa.”
A quarter of a million people are effected by diabetes in Scotland, with 13% living with type 1 diabetes and 87% living with type 2 diabetes.
Dexcom operates internationally and is headquartered in San Diego, California.
